Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

A young woman's rare ovarian tumor was successfully removed, improving her hormonal symptoms.

A new method was created to analyze certain chemicals in the urine of alopecia areata patients, revealing they have higher metanephrine content. This method can also be used for other related diseases.

Low dose finasteride decreases certain steroids, possibly increasing depression risk.

Androsterone and finasteride have different solid forms, with new findings correcting previous errors and identifying a new form.

The research found that measuring androgens in urine can give extra information about body metabolism and is linked to androgen levels in the blood, especially in young girls.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Finasteride effectively reduces hair loss by decreasing androgen levels.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

A boy with a rare skin condition and kidney disease improved with cyclosporine after steroids failed, suggesting a new treatment approach.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Some birth control pills can cause hair loss, and switching to ones with less androgen should help.

Men with high testosterone may have higher morning blood pressure, unlike those with high DHT.

Skin lesions in Carney complex are likely caused by a specific group of skin cells that promote pigment production due to a genetic mutation.

Clofazimine may be effective for treating ashy dermatosis.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Neutered ferrets often develop hyperadrenocorticism, with symptoms like hair loss and lethargy, and androstenedione is a key indicator for diagnosis.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.